A young woman given a renal allograft for polycystic kidney disease developed insulin dependent diabetes mellitus 25 days after transplantation. There was no family history of diabetes, plasma glucose concentrations had been normal at presentation and on five subsequent occasions, and at no time were islet cell antibodies detectable. Plasma C peptide concentrations, however, were greatly suppressed after transplantation and remained so for up to six months.
Introduction
Cyclosporin A is a fungal metabolite with unique T lymphocyte suppressive effects which can prevent transplant rejection. It has recently been used to treat newly diagnosed insulin dependent diabetes mellitus-a disease known to be associated with an autoimmune process-in an attempt to improve the rate and duration of remission.' Recent work suggests, however, that cyclosporin may be toxic to 1 cells,2 though this remains controversial. 3 We report the case of a young woman who developed insulin dependent diabetes after renal transplantation for non-diabetic renal disease. Cyclosporin Alternatively, diabetes may have occurred spontaneously, withdrawal ofinsulin coinciding with the remission ("honeymoon") period that occurs after treatment in some patients. It is uncommon, however, for young patients to become insulin independent with normal glucose tolerance for more than 18 months after the initial diagnosis and in the presence of continued prednisolone treatment. Moreover, the patient had no family history of diabetes and no detectable islet cell antibodies at the time of diagnosis.
We are left with the possibility that diabetes was induced by cyclosporin. Though cyclosporin has prevented the development of insulin dependent diabetes in spontaneously diabetic animal models, it inhibited I6 cell proinsulin biosynthesis and insulin release in cultured mouse and human pancreatic islets.' The association of C peptide depression with high blood cyclosporin concentrations in our patient may be relevant.
The suggestion that cyclosporin may be associated with the appearance of post-transplantation diabetes in renal allograft recipients2-has not been confirmed by other workers, who found that this occurs regardless of the immunosuppressive regimen and whether or not cyclosporin is included. 3 We suggest that dose related fi cell toxicity of cyclosporin A may be a risk in recipients of the drug. This phenomenon appears to be reversible by reducing the dose and underlines the need for careful monitoring of drug and glucoseconcentrations.
We
Snakebite is a common medical emergency in many tropical countries. Most patients do not provide conclusive evidence of the species that bit them by bringing the dead snake with them to the hospital. In some instances, even when the snakes are brought, the medical staff are unable to identify them. Clinical diagnosis based on signs and symptoms may be very misleading. For example, in Thailand the Malayan pit viper (Calloselasma rhodostoma), green pit viper (Trimeresurus albolabris), and Russell's viper (Vipera russelli), all produce a similar syndrome of local swelling, spontaneous bleeding, and no blood clotting. In the absence of a dead snake or in a case ofmistaken identification the wrong monospecific antivenom may be given to the patient. Identification ofthe snake that bit them is therefore of the utmost importance for the proper management of patients with snakebite.
The application of the enzyme linked immunosorbent assay (ELISA) to identifying the biting species in cases of snakebite was first described by Theakston et al.' Since then diagnostic kits based on the assay and prepared by the Commonwealth Serum Laboratory in Australia have been used with some success.23 ELISA has also been used in snakebite studies in Malaysia, Burma, Thailand, .the United States, and Ecuador.49 Modifications of the original test have been found to be necessary to minimise the problems of nonspecific reactivity and cross reactivity encountered commonly with serum specimens from rural populations in the tropics. 10 The present study was undertaken to determine the incidence of systemic envenoming among snakebite victims and to validate the modified ELISA procedure" for the large scale testing of serum samples collected by paramedical staff in rural Thailand.
Patients and methods
As part of a countrywide survey conducted in Thailand to determine the distribution of snake species causing morbidity and mortality the nursing staff in provincial hospitals were requested to record on standard forms the history and clinical signs ofevery patient who presented with snakebite. The signs sought were local swelling; bleeding from the site of the bite and gums
